Literature DB >> 25922403

Current Trends in the Epidemiology and Outcomes of Clostridium difficile Infection.

Charlesnika T Evans1, Nasia Safdar2.   

Abstract

Clostridium difficile is the most frequently identified cause of nosocomial diarrhea and has been associated with epidemics of diarrhea in hospitals and long-term care facilities. The continued increase in C. difficile infection (CDI) suggests that it has surpassed other pathogens in causing healthcare-associated infections. The Centers for Disease Control and Prevention recently identified CDI as an "urgent threat" in its recent report on antibiotic resistance threats in the United States, highlighting the need for urgent and aggressive action to prevent this infection. The impact of antibiotics as a risk factor for new-onset CDI is well established; however, recognizing classes of antibiotics with the highest risks and reducing unnecessary antibiotic use are important strategies for prevention of CDI and subsequent recurrence. In addition, the recognition of the community as an important setting for onset of CDI presents a challenge and is an area for future research. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  Clostridium difficile; costs; epidemiology

Mesh:

Substances:

Year:  2015        PMID: 25922403     DOI: 10.1093/cid/civ140

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  74 in total

1.  Building a Better Crystal Ball for Predicting Complications of Clostridium difficile Infection.

Authors:  David M Aronoff
Journal:  Clin Infect Dis       Date:  2015-09-03       Impact factor: 9.079

2.  Indomethacin increases severity of Clostridium difficile infection in mouse model.

Authors:  Juan Muñoz-Miralles; Bruno C Trindade; Pablo Castro-Córdova; Ingrid L Bergin; Leslie A Kirk; Fernando Gil; David M Aronoff; Daniel Paredes-Sabja
Journal:  Future Microbiol       Date:  2018-09-21       Impact factor: 3.165

3.  Cost-Effectiveness Analysis of Four Common Diagnostic Methods for Clostridioides difficile Infection.

Authors:  Si Xuan; Kenneth M Zangwill; Weiyi Ni; Junjie Ma; Joel W Hay
Journal:  J Gen Intern Med       Date:  2020-02-03       Impact factor: 5.128

Review 4.  Hospital Infection Control: Clostridioides difficile.

Authors:  Nicholas A Turner; Deverick J Anderson
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

5.  The non-toxigenic Clostridium difficile CD37 protects mice against infection with a BI/NAP1/027 type of C. difficile strain.

Authors:  Keshan Zhang; Song Zhao; Yuankai Wang; Xuejun Zhu; Hong Shen; Yugen Chen; Xingmin Sun
Journal:  Anaerobe       Date:  2015-10-13       Impact factor: 3.331

6.  Identification of Clostridium difficile Immunoreactive Spore Proteins of the Epidemic Strain R20291.

Authors:  Marjorie Pizarro-Guajardo; María Cristina Ravanal; Maria Daniela Paez; Eduardo Callegari; Daniel Paredes-Sabja
Journal:  Proteomics Clin Appl       Date:  2018-04-18       Impact factor: 3.494

7.  PURL: Do probiotics reduce C diff risk in hospitalized patients?

Authors:  Matthew Simpson; Corey Lyon
Journal:  J Fam Pract       Date:  2019 Jul/Aug       Impact factor: 0.493

8.  Acute Kidney Injury Due to Diarrheal Illness Requiring Hospitalization: Data from the National Inpatient Sample.

Authors:  Christina Bradshaw; Yuanchao Zheng; Samuel A Silver; Glenn M Chertow; Jin Long; Shuchi Anand
Journal:  J Gen Intern Med       Date:  2018-06-18       Impact factor: 5.128

9.  Electronically Available Comorbid Conditions for Risk Prediction of Healthcare-Associated Clostridium difficile Infection.

Authors:  Anthony D Harris; Alyssa N Sbarra; Surbhi Leekha; Sarah S Jackson; J Kristie Johnson; Lisa Pineles; Kerri A Thom
Journal:  Infect Control Hosp Epidemiol       Date:  2018-02-05       Impact factor: 3.254

10.  High Prevalence and Genetic Diversity of Large phiCD211 (phiCDIF1296T)-Like Prophages in Clostridioides difficile.

Authors:  Julian R Garneau; Ognjen Sekulovic; Bruno Dupuy; Olga Soutourina; Marc Monot; Louis-Charles Fortier
Journal:  Appl Environ Microbiol       Date:  2018-01-17       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.